WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences and Photonics, today announced that Specimen Gate®, its specialized information management solution for genetic screening laboratories, has been deployed across more than 70 countries, states and provinces worldwide. The Specimen Gate product portfolio is a critical element of both neonatal and prenatal screening programs, many of which are implemented at the state or national levels of countries around the world, resulting in the identification of thousands of infants at risk of genetic disease each year. As genetic screening programs continue to expand globally, and the demand for world-class information management systems grows, PerkinElmer expects Specimen Gate-based installations to double by 2010.
